We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.


Behavioral Neuroscience – Products

The Neuralace, an ultra high-channel neural implant.
Product News

Blackrock Neurotech Reveals Neuralace™: 10,000+ Channel Next-Gen BCI

Blackrock Neurotech revealed its next-generation neural interface, Neuralace™, at Society for Neuroscience 2022.
Ann Kennedy, PhD, Assistant Professor at Northwestern University, Chicago.
Product News

Research on Neural Dynamics Wins 2022 Eppendorf & Science Prize

The American scientist Ann Kennedy, PhD, assistant professor at Northwestern University, Chicago, USA has won the 2022 Eppendorf & Science Prize for Neurobiology for her work on the neural population dynamics that generate and maintain our emotions and behavioral drives.
Product News

Suzanne Foster Appointed President of Beckman Coulter Life Sciences

Beckman Coulter Life Sciences announces that Suzanne Foster has been appointed as President of the company.
Product News

Beckman Coulter Introduces Antipsychotic Drug Testing To Address Unmet Clinical Need for More Than 69 Million People Living With Serious Mental Conditions

Beckman Coulter announces it will introduce new antipsychotic drug tests to laboratories and clinicians to address an unmet clinical need for 69 million people with serious mental conditions worldwide.
Product News

Research on Hunger Wins 2021 Eppendorf & Science Prize

The American scientist Amber L. Alhadeff, Ph.D., Principal Investigator at the Monell Chemical Senses Center and the University of Pennsylvania, USA has won the 2021 Eppendorf & Science Prize for Neurobiology for her work on the gut-brain control of hunger circuits.
Product News

Wesana Health Commits Funding of $1.5 Million To Support MAPS’ Research Pipeline

Wesana Health announced its commitment to fund an initial US $1.5 million to assess the viability of Multidisciplinary Association for Psychedelic Studies (MAPS) MDMA-assisted therapy to treat traumatic brain injury (TBI).

Water Maze Testing and Alzheimer's Research

Alzheimer’s disease (AD) is the most common form of dementia, and it is also one of the most common neurodegenerative diseases. AD comes with memory impairments, and as a result many of the neurobehavioral studies done on AD involve the water maze test.
Product News

The Centre For Cognitive Neuroimaging (CCNi) To Acquire A TRIUX™ neo

MEGIN is pleased to announce the acquisition of a TRIUX™ neo by The Centre For Cognitive Neuroimaging at the Institute for Neuroscience and Psychology at the University of Glasgow. This research facility will continue its role as the only MEG site in Scotland, continuously supporting neuroimaging related research.
Product News

Linkam FDCS196 Stage Used To Develop a Novel Transdermal Delivery System for Risperidone

A recent study describes for the first time the formation of room temperature therapeutic deep eutectic solvent (THEDES) of RIS, an antipsychotic drug that is used in the treatment of schizophrenia, mixed and manic states associated with bipolar disorder and irritability in children and adolescents with autism.
Product News

Study Finds Chatbot Reduced Problematic Substance Use During Pandemic

Woebot Health has announced that the Journal of Medical Internet Research (JMIR), has published the results of its latest study. The study is one of the first to explore substance use disorder interventions via mobile apps.